Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

New HRT patch approved for launch in U.S.

Jan. 3, 1997

Generic antidiabetic agent approved by FDA

Jan. 3, 1997

FDA advisory panel to discuss penile implant guidelines

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Fluoxetine plus dexfenfluramine effective in obese patients

Jan. 3, 1997

Lilly claims IGF-1 superagonists

Jan. 3, 1997

New vitamin D derivatives from Duphar

Jan. 3, 1997

Japanese researchers focus on pyripyropenes

Jan. 3, 1997

Norian begins trial of Norian SRS in hip fractures

Jan. 2, 1997

Osiris provides funds for clinical trial of hMSCs

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...